Citalopram Provides Little or No Benefit in Nondepressed Patients With Irritable Bowel Syndrome
- 18 September 2009
- journal article
- research article
- Published by Elsevier BV in Clinical Gastroenterology and Hepatology
- Vol. 8 (1), 42-48.e1
- https://doi.org/10.1016/j.cgh.2009.09.008
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- Efficacy of antidepressants and psychological therapies in irritable bowel syndrome: systematic review and meta-analysisGut, 2008
- Effects of 5-Hydroxytryptamine (Serotonin) Type 3 Antagonists on Symptom Relief and Constipation in Nonconstipated Irritable Bowel Syndrome: A Systematic Review and Meta-Analysis of Randomized Controlled TrialsClinical Gastroenterology and Hepatology, 2008
- Antidepressants for the Treatment of Chronic PainDrugs, 2008
- Antidepressant Therapy (Imipramine and Citalopram) for Irritable Bowel Syndrome: A Double-Blind, Randomized, Placebo-Controlled TrialDigestive Diseases and Sciences, 2007
- Has the identification of rectal hypersensitivity any implication in the clinical outcome of irritable bowel syndrome?Revista Española de Enfermedades Digestivas, 2005
- The selective serotonin reuptake inhibitor fluoxetine does not change rectal sensitivity and symptoms in patients with irritable bowel syndrome: A double blind, randomized, placebo-controlled studyClinical Gastroenterology and Hepatology, 2003
- The selective serotonin reuptake inhibitor fluoxetine does not change rectal sensitivity and symptoms in patients with irritable bowel syndrome: A double blind, randomized, placebo-controlled studyClinical Gastroenterology and Hepatology, 2003
- Testing the sensitivity hypothesis in practice: tools and methods, assumptions and pitfallsGut, 2002
- Rome II: the Functional Gastrointestinal Disorders. Diagnosis, Pathophysiology and Treatment: a Multinational ConsensusGut, 2000
- ReplyGastroenterology, 1998